Skip to content
PIL Logo

Zypadhera 210mg, 300mg and 405mg powder and solvent for prolonged release suspension for injection

Last Updated on eMC 06-Mar-2017 View changes  | Eli Lilly and Company Limited Contact details

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Company contact details

Eli Lilly and Company Limited

Company image

Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL


+44 (0)1256 775 858

Medical Information Fax

+44 (0)1256 775 569


+44 (0)1256 315 000

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

olanzapine pamoate monohydrate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue